Case Report: Tislelizumab–induced panuveitis: a report of two cases
Prompt Tislelizumab discontinuation combined with local corticosteroid therapy-transcutaneous periocular TA injections, and topical steroid eye drops may constitute an effective management strategy for ICIs-induced uveitis. This approach is particularly valuable for cancer patients in whom systemic corticosteroids are contraindicated or unsuitable.
Authors
- Huan Ding (ORCID: https://orcid.org/0000-0002-1676-473X)
- Kaiyan Zhang
- Lin Lin (ORCID: https://orcid.org/0000-0002-2752-6251)
- Shuyuan Zhang (ORCID: https://orcid.org/0000-0002-6220-5998)
Institutions
- Hainan General Hospital (CN)
- Hainan Medical University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-12-19
- DOI
- https://doi.org/10.3389/fphar.2025.1678663
- Primary Topic
- Ocular Diseases and Behçet’s Syndrome
- Type
- article
- Field-Weighted Citation Impact
- 0.00